Skip to Content

Join the 'Ovarian Cancer' group to help and get support from people like you.

Ovarian Cancer News

Related terms: Cancer, Ovarian, Cancer, Ovaries

Treatment Costs Can Be Another Blow to Cancer Patients

Posted 10 hours ago by Drugs.com

THURSDAY, July 27, 2017 – The emotional and physical costs of cancer can be staggering. But the financial side of cancer is also a great burden, with many patients in the United States struggling to pay for treatment, new research reveals. "The current health law has greatly improved access to meaningful health coverage for cancer patients, survivors and all those with chronic diseases," Chris Hansen, president of the American Cancer Society Cancer Action Network, said in a network news release. "Yet costs remain a challenge for those facing cancer. Our country and our lawmakers should come together to find bipartisan solutions that begin to address patient costs without sacrificing the quality of coverage," he urged. Researchers surveyed financial navigators at 11 hospitals in nine states. Financial navigators – typically trained social workers or nurses – help cancer patients ... Read more

Related support groups: Cancer, Depo-Provera, Provera, Breast Cancer, Lupron, Prostate Cancer, Medroxyprogesterone, Tamoxifen, Arimidex, Lupron Depot, Femara, Gleevec, Lung Cancer, Colorectal Cancer, Non-Small Cell Lung Cancer, Anastrozole, Brain Tumor, Tarceva, Letrozole, Skin Cancer

Many Terminal Cancer Patients Remain in Denial

Posted 8 days ago by Drugs.com

WEDNESDAY, July 19, 2017 – Nearly 10 percent of patients with terminal cancer don't want to know they're dying, which can make their final days more difficult, a new study finds. Unwillingness to face poor prospects can lead to unnecessary treatments and keep patients from making end-of-life plans, the researchers reported recently in The Oncologist. "Health care professionals should appropriately assess patients' readiness for prognostic information," said study leader Siew-Tzuh Tang, a professor at Chang Gung University School of Nursing in Taiwan. Doctors should respect patients' reluctance to confront their poor prognosis if they are not ready to know, "but sensitively coach them to cultivate their accurate prognostic awareness," Tang said in a journal news release. The study involved nearly 250 terminal cancer patients in Taiwan. They were questioned several times over their last ... Read more

Related support groups: Anxiety, Generalized Anxiety Disorder, Anxiety and Stress, Cancer, Post Traumatic Stress Disorder, Social Anxiety Disorder, Breast Cancer, Prostate Cancer, Lung Cancer, Renal Cell Carcinoma, Colorectal Cancer, Non-Small Cell Lung Cancer, Breast Cancer, Metastatic, Brain Tumor, Skin Cancer, Ovarian Cancer, Pancreatic Cancer, Cervical Cancer, Stomach Cancer, Breast Cancer, Prevention

Doctors' Group Offers Ideas for Easing Cancer Costs

Posted 9 days ago by Drugs.com

WEDNESDAY, July 19, 2017 – New cancer drugs routinely cost $100,000 a year or more, and older cancer drugs are rising in price, too. Now, the American Society of Clinical Oncology (ASCO) has some suggestions for easing patients' money woes. The proposals include allowing Medicare to negotiate drug prices, legalizing the importation of drugs, and adopting bundled, or group, payment programs. In the new policy statement, ASCO also says it supports creation of a panel of "stakeholders" in health care to determine the effectiveness of its proposals. Such a group might also outline a uniform approach for assessing the value of drugs. "In what, undoubtedly, is one of the most difficult times in their lives, individuals with cancer should be focused on getting the best care possible, not worrying about financial strain on their families," said Dr. Clifford Hudis. He's CEO of ASCO, a leading ... Read more

Related support groups: Cancer, Depo-Provera, Provera, Methotrexate, Breast Cancer, Lupron, Prostate Cancer, Medroxyprogesterone, Tamoxifen, Arimidex, Fluorouracil, Lupron Depot, Femara, Gleevec, Lung Cancer, Colorectal Cancer, Votrient, Anastrozole, Brain Tumor, Letrozole

Most Women Should Forgo Ovarian Cancer Screening: Panel

Posted 9 days ago by Drugs.com

TUESDAY, July 18, 2017 – The potential harms of ovarian cancer screening outweigh the benefits, so only very specific groups of women should be screened for the disease, the U.S. Preventive Services Task Force (USPSTF) says in a draft recommendation. "The task force found that screening women without signs or symptoms for ovarian cancer does not decrease the number of deaths from the disease, and may lead to unnecessary surgeries," Dr. Maureen Phipps said in a news release from the USPSTF. "Therefore, the task force recommends against screening for ovarian cancer in women who have no signs or symptoms, and who are not at high risk for ovarian cancer," she said. Phipps is a member of the task force, which is an independent, volunteer panel of national experts in prevention and evidence-based medicine. The new guidance reaffirms a 2012 final recommendation made by the USPSTF. Task force ... Read more

Related support groups: Ovarian Cancer, Diagnosis and Investigation, Body Imaging

When Is Risk Highest for Women With Breast Cancer Gene Mutations?

Posted 20 Jun 2017 by Drugs.com

TUESDAY, June 20, 2017 – For women who have genetic mutations that increase their risk of breast and ovarian cancers, researchers have better defined at what age those gene flaws are most likely to cause trouble. Knowing when gene-based cancer risks peak in a woman's life will help doctors and patients decide when to take drastic steps such as removing a breast or the ovaries to prevent cancer, said study senior author Antonis Antoniou. He's a researcher with the University of Cambridge's Department of Public Health and Primary Care in England. Breast cancer risk peaks around the 40s for BRCA1 mutation carriers and around the 50s for BRCA2 carriers, Antoniou said. "This gives women more guidance as to when it's safe to wait and when it's time to go ahead and do the surgery," said study co-author Dr. Mary Daly, founder and director of Fox Chase Cancer Center's Risk Assessment Program in ... Read more

Related support groups: Breast Cancer, Ovarian Cancer, Breast Cancer, Prevention, Diagnosis and Investigation

High Blood Pressure: A Silver Lining for Ovarian Cancer Patients?

Posted 19 Apr 2017 by Drugs.com

TUESDAY, April 18, 2017 – A woman's prognosis after an ovarian cancer diagnosis may be affected by a number of unexpected factors, new research suggests. The study found that diabetes is linked to a 112 percent higher risk of death for women with ovarian cancer. The research also showed that women with a specific type of ovarian cancer actually seemed to benefit from having a high blood pressure (hypertension) diagnosis. "This is a coincidental and unintended consequence of hypertension and its treatment," said study co-lead author Kirsten Moysich. She's a professor of oncology at Roswell Park Cancer Institute in Buffalo, N.Y. "But it's a silver lining to a serious but largely manageable medical condition that has reached epidemic prevalence in the U.S. and many other countries worldwide," Moysich said in an institute news release. The researchers reviewed data from 15 studies of ... Read more

Related support groups: High Blood Pressure, Hypertension, Ovarian Cancer, Hypertensive Heart Disease

Sexual Abuse May Cause Early Puberty in Girls: Study

Posted 31 Mar 2017 by Drugs.com

FRIDAY, March 31, 2017 – It's common for parents to worry that their kids are growing up too fast. But in certain cases, early puberty in girls may be linked to sexual abuse, a small study suggests. Pennsylvania State University researchers examined data from 84 girls with a history of sexual abuse and 89 girls with no history of abuse. Those who were abused entered puberty eight to 12 months earlier than those who weren't abused, the investigators found. "Though a year's difference may seem trivial in the grand scheme of a life, this accelerated maturation has been linked to concerning consequences, including behavioral and mental health problems, and reproductive cancers," said study author Jennie Noll. She is director of the Child Maltreatment Solutions Network at Penn State. Typically, children's physical and mental development occur in tandem. "High-stress situations, such as ... Read more

Related support groups: Post Traumatic Stress Disorder, Breast Cancer, Ovarian Cancer, Precocious Puberty, Sexual Deviations or Disorders

Survival Continues to Improve for Most Cancers

Posted 31 Mar 2017 by Drugs.com

FRIDAY, March 31, 2017 – Overall cancer death rates in the United States continue to fall, but racial gaps persist, a new report says. Death rates fell between 2010 and 2014 for 11 of the 16 most common cancers in men and for 13 of the most common types in women, including lung, colon, prostate and breast cancers. However, death rates rose for cancers of the liver, pancreas and brain in men and for the liver and uterus in women. And improvements in cancer survival weren't equal for all Americans. "While this report found that five-year survival for most types of cancer improved among both blacks and whites over the past several decades, racial disparities for many common cancers have persisted, and they may have increased for prostate cancer and female breast cancer," said Dr. Lynne Penberthy. She's associate director of the U.S. National Cancer Institute's Surveillance Research ... Read more

Related support groups: Cancer, Breast Cancer, Prostate Cancer, Lung Cancer, Renal Cell Carcinoma, Colorectal Cancer, Non-Small Cell Lung Cancer, Breast Cancer, Metastatic, Brain Tumor, Melanoma, Skin Cancer, Ovarian Cancer, Pancreatic Cancer, Osteosarcoma, Endometrial Cancer, Small Cell Lung Cancer, Breast Cancer - Adjuvant, Bladder Cancer, Cervical Cancer, Melanoma - Metastatic

Many Women Who Get Breast Cancer Gene Test Don't Need It

Posted 28 Mar 2017 by Drugs.com

TUESDAY, March 28, 2017 – An increasing number of American women who don't have breast or ovarian cancer are being tested for BRCA and BRCA2 gene mutations associated with those diseases, a new study shows. Mutations in the BRCA1 and BRCA2 genes significantly increase a woman's risk of breast cancer. These mutations are linked to 5 percent to 10 percent of all breast cancer and about 15 percent of ovarian cancers, the U.S. National Cancer Institute says. The new study found that more than 60 percent of BRCA tests are done on women without breast or ovarian cancer. In 2004, that number was just 24 percent. This increase is likely due to increased marketing of BRCA testing. This may lead women at low risk for BRCA mutations to self-refer for testing, the researchers said. While the number of low-risk women being tested has increased, BRCA testing is being underused by at-risk women, the ... Read more

Related support groups: Breast Cancer, Breast Cancer, Metastatic, Ovarian Cancer, Breast Cancer, Prevention, Diagnosis and Investigation

Zejula Approved for Certain Female Cancers

Posted 28 Mar 2017 by Drugs.com

TUESDAY, March 28, 2017 – Zejula (niraparib) has been approved by the U.S. Food and Drug Administration to treat adult women with recurring cancers of the ovaries, fallopian tubes or abdominal wall (peritoneum) whose tumors have shrunk in response to platinum-based chemotherapy. Citing the National Cancer Institute, the FDA said in a news release that more than 22,000 women are expected to be diagnosed with these cancers this year, and more than 14,000 will die of these diseases. Zejula is designed to block an enzyme involved in repairing damaged DNA. The thought is that by blocking this enzyme, cancer cells would die and slow down or stop tumor growth, the FDA said. The drug was evaluated in clinical studies involving 553 people with any of these recurring cancers who had had their tumors shrunk by at least two doses of platinum-based chemotherapy. The average progression-free ... Read more

Related support groups: Cancer, Ovarian Cancer, Zejula, Peritoneal Cancer, Solid Tumors, Niraparib

Tesaro Announces FDA Approval of Zejula (niraparib) for Women with Recurrent Ovarian Cancer

Posted 27 Mar 2017 by Drugs.com

WALTHAM, MA, March 27, 2017 – Tesaro, Inc. (NASDAQ: TSRO), an oncology-focused biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has approved Zejula (niraparib), an oral, once-daily poly(ADP-ribose) polymerase (PARP) inhibitor, for the maintenance treatment of women with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in a complete or partial response (CR or PR) to platinum-based chemotherapy. Zejula is the first PARP inhibitor to be approved by the FDA that does not require BRCA mutation or other biomarker testing. Tesaro anticipates launching Zejula in the United States in late April. Zejula is the only PARP inhibitor that has demonstrated a clinically meaningful increase in progression-free survival (PFS) in women with recurrent ovarian cancer, regardless of BRCA mutation or biomarker status, in a r ... Read more

Related support groups: Cancer, Ovarian Cancer, Zejula, Peritoneal Cancer, Fallopian Tube Cancer, Niraparib

Another Study Ties Obesity to Certain Cancers

Posted 1 Mar 2017 by Drugs.com

WEDNESDAY, March 1, 2017 – Carrying extra weight increases the risk of a number of cancers, a new review reports. Additional pounds appear to particularly influence the risk of cancers related to the digestive organs or those driven by hormonal abnormalities, according to the review's European authors. The evidence is so strong at this point that important organizations such as the International Agency for Research on Cancer describe "excess body weight as an important cause of cancers," said Susan Gapstur. She's vice president of epidemiology at the American Cancer Society. The new evidence review was led by Maria Kyrgiou, of Imperial College London's Department of Surgery and Cancer. The review found that a jump in a person's body mass index (BMI) of 5 was associated with a higher cancer risk in the esophagus, bone marrow, biliary tract system, pancreas and kidneys. BMI is a rough ... Read more

Related support groups: Obesity, Cancer, Weight Loss, Breast Cancer, Prostate Cancer, Renal Cell Carcinoma, Colorectal Cancer, Ovarian Cancer, Pancreatic Cancer, Endometrial Cancer, Stomach Cancer, Gastric Cancer, Wilms' Tumor, Peritoneal Cancer, Solid Tumors, Neoplasm of Bone, Insulinoma, Giant Cell Tumor of Bone

Cancer Survivors Gain From Web-Based Health Care

Posted 10 Feb 2017 by Drugs.com

FRIDAY, Feb. 10, 2017 – Online- and phone-based health care offers a number of benefits for cancer survivors, British researchers report. The new study looked at previous research on cancer survivors' experiences with online and phone health contacts – what the researchers call telehealth. The review found that patients liked the flexibility and convenience of this method of staying in touch with their care providers because they could do so in a familiar, comfortable setting and with minimum disruption to their lives. The perceived anonymity of telehealth reduced patients' sense of vulnerability and some said they were more comfortable raising concerns in this setting than in face-to-face appointments. Negative aspects of telehealth mentioned by patients included not being able to meet their health care providers in person, while other patients said they couldn't use the service due ... Read more

Related support groups: Cancer, Prostate Cancer, Lung Cancer, Colorectal Cancer, Non-Small Cell Lung Cancer, Breast Cancer, Metastatic, Brain Tumor, Skin Cancer, Ovarian Cancer, Small Cell Lung Cancer, Bladder Cancer, Cervical Cancer, Stomach Cancer, Breast Cancer, Prevention, Head and Neck Cancer, Breast Cancer - Palliative, Testicular Cancer, Zollinger-Ellison Syndrome, Wilms' Tumor, Solid Tumors

Too Few High-Risk Women Tested for Breast Cancer Gene: Survey

Posted 7 Feb 2017 by Drugs.com

TUESDAY, Feb. 7, 2017 – Though testing for two genes that raise breast cancer risk has been around for decades, a new survey finds many high-risk women don't get the test, often because they aren't told to by their doctors. Among women with the highest risk, about eight of 10 said they wanted testing for the BRCA1 and BRCA2 mutations. But, "only about half of them actually got the testing they should get," said study author Dr. Allison Kurian, from Stanford University's School of Medicine. "Genetic cancer testing is not well matched to the medical needs of the patient, to a woman's risk of having a mutation," said Kurian, an associate professor of medicine and of health research and policy. Why the gap? About 56 percent of the high-risk women who were not tested said their doctors did not recommend it, the survey found. In addition to the test itself, genetic counseling can help ... Read more

Related support groups: Breast Cancer, Breast Cancer, Metastatic, Ovarian Cancer, Breast Cancer, Prevention, Diagnosis and Investigation, Breast Cancer - Palliative, Osteolytic Bone Metastases of Breast Cancer

Know the Risks, Warning Signs of Ovarian Cancer

Posted 19 Jan 2017 by Drugs.com

WEDNESDAY, Jan. 18, 2017 – Women need to be aware their risk for ovarian cancer increases with age. Half of all cases affect women age 63 or older, according to specialists at Fox Chase Cancer Center in Philadelphia. However, the center reminds all women to be aware of other risk factors for the disease, as well as common ovarian cancer warning signs, such as: Belly bloating or swelling, Lower belly pain, Back pain, Trouble eating or feeling full quickly, Unexplained weight loss, Pain during sex, Menstrual changes, A change in bathroom habits, such as constipation, diarrhea, or having to urinate very badly or very often. "While these symptoms are common and may be caused by something other than ovarian cancer, I advise women to take them seriously," said Dr. Christina Chu, a Fox Chase gynecologic oncologist. "A woman knows what is normal for her own body. If her symptoms don't seem ... Read more

Related support groups: Birth Control, Contraception, Plan B, Cancer, Emergency Contraception, Mirena, Nexplanon, Depo-Provera, Provera, NuvaRing, Sprintec, Implanon, Urinary Tract Infection, Ortho Tri-Cyclen, Tri-Sprintec, Microgestin Fe 1/20, Yasmin, Plan B One-Step, Loestrin 24 Fe, Ortho Evra

Page 1 2 3 ... Next

Ask a Question

Further Information

Related Condition Support Groups

Cancer

Related Drug Support Groups

methotrexate, Avastin, Taxol, carboplatin, cisplatin, Cytoxan, cyclophosphamide, paclitaxel, Gemzar, view more... gemcitabine, doxorubicin, Adriamycin, Zejula, bevacizumab, topotecan, Hycamtin, etoposide, Alkeran, Lynparza, amifostine, Rubraca, Platinol, Doxil, Hexalen, Neosar, melphalan, thiotepa, olaparib, Adriamycin PFS, Thioplex, Adriamycin RDF, Etopophos, Tepadina, dactinomycin, doxorubicin liposomal, VePesid, Platinol-AQ, Carboplatin Novaplus, Onxol, Paraplatin, altretamine, Ethyol, niraparib, Cytoxan Lyophilized, Cosmegen, rucaparib, Toposar